2024 HCPCS Code J7639
Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
TAGS: final dornase inhalation through milligram administered
Short Description | Dornase alfa non-comp unit |
Product Note | 0135 |
HCPCS Coverage Code | D - Special coverage instructions apply |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Action Effective Date | January 01, 2009 |
HCPCS Code Added Date | January 01, 2000 |
HCPCS Pricing Indicator Code | 51 - Drugs |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Coverage Issues Manual Reference Section Number | |
HCPCS Type Of Service Code | 1 - Medical care |
HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- J2186 - Inj., meropenem, vaborbactam
- J2210 - Methylergonovin maleate inj
- J2212 - Methylnaltrexone injection
- J2246 - Inj, micafungin (baxter)
- J2247 - Inj, micafungin (par pharm)
- J2248 - Micafungin sodium injection
- J2249 - Inj, remimazolam, 1 mg
- J2250 - Inj midazolam hydrochloride
- J2251 - Inj midazolam (wg crit care)
- J2260 - Inj milrinone lactate / 5 mg
- J2265 - Minocycline hydrochloride
- J2267 - Inj, mirikizumab-mrkz, 1 mg
- J2270 - Morphine sulfate injection
- J2271 - Morphine so4 injection 100mg
- J2272 - Inj, morphine (fresenius)
- J2274 - Inj morphine pf epid ithc
- J2275 - Morphine sulfate injection
- J2277 - Inj, motixafortide, 0.25 mg
- J2278 - Ziconotide injection
- J2280 - Inj, moxifloxacin 100 mg